Seoul, South Korea

Jang Jiyeon

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignees: Institut Pasteur Korea, National Institute of Health and Medical Research. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jang Jiyeon. Retrieved from https://idiyas.com/inventor/jang-jiyeon

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


 

Average Co-Inventor Count = 16.0

ph-index = 1

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Jang Jiyeon

Introduction

Jang Jiyeon, an accomplished inventor based in Seoul, South Korea, has made significant strides in the realm of medical advancements. With a focus on tackling bacterial infections, particularly Tuberculosis, Jang's innovative contributions showcase his dedication to improving global health.

Latest Patents

Jang Jiyeon holds one patent for his groundbreaking work on anti-infective compounds. This invention involves small molecule compounds that are specifically designed for the treatment of bacterial infections, especially targeting Tuberculosis. His research is pivotal in developing more effective treatment options for one of the world's deadliest diseases.

Career Highlights

Throughout his illustrious career, Jang has worked with prominent research institutions, including Institut Pasteur Korea and the Institut National de la Santé et de la Recherche Médicale. His experience in these esteemed organizations has allowed him to hone his skills in research and innovation, ultimately leading to his notable patent.

Collaborations

In his journey as an inventor, Jang Jiyeon has collaborated with esteemed colleagues in his field, including Zaesung No and Jaeseung Kim. These collaborations have enhanced his research efforts, driving forward the development of valuable medical treatments.

Conclusion

Jang Jiyeon's innovative work in developing anti-infective compounds spotlights his commitment to addressing critical health challenges. As he continues to contribute to medical science through his patents and collaborations, the impact of his inventions will surely resonate within the healthcare community and beyond.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…